• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

Israel panel recommends fourth vaccine dose for adults 18 and over

By
Alisa Odenheimer
Alisa Odenheimer
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Alisa Odenheimer
Alisa Odenheimer
and
Bloomberg
Bloomberg
Down Arrow Button Icon
January 25, 2022, 11:04 AM ET

A panel of Israeli health experts has recommended offering a fourth dose of coronavirus vaccine to all adults age 18 and over. 

The shot would be administered only to those who received the vaccine at least five months earlier or recovered from coronavirus at least five months before, the Health Ministry said in a text message. The ministry’s director-general, Nachman Ash, would have to approve the recommendation for it to go into effect. 

The recommendation was made after a ministry study showed that the fourth dose provided three to five times more protection against serious illness, and twice as much protection against infection than just a third dose. Israel began administering a fourth inoculation to the immunocompromised and people 60 and over earlier this month. 

Infectious disease specialist Eyal Leshem of Sheba Medical Center questioned the ministry’s findings, saying the people who chose to have the fourth dose may also be more likely to avoid risky exposure to infection, skewing the results of the comparison. 

While a fourth dose may be a good idea for senior citizens or those who suffer from chronic illness, it isn’t necessary for younger adults, Leshem said. The vaccines could be put to better use in countries where inoculation rates are low, he said. 

“Three doses of the vaccine provide excellent protection against severe disease for young and healthy people, and the added value for a fourth dose is currently unknown and not expected to be substantial,” he said. “From a global perspective, use of multiple boosters in low-risk populations during a short period should be weighed against the global shortage of COVID vaccines.”

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Authors
By Alisa Odenheimer
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.